imodium 2 mg tabletter
2care4 aps - loperamidhydrochlorid - tabletter - 2 mg
imodium 2 mg tabletter
paranova danmark a/s - loperamidhydrochlorid - tabletter - 2 mg
sodium chromate (51 cr) solution, ge healthcare radiofarmaceutisk mærkningsopløsning
ge healthcare limited - natriumkromat (51-cr) - radiofarmaceutisk mærkningsopløsning
sodium iodide (123 i) injection "ge healthcare" injektionsvæske
ge healthcare b.v. - natriumiodid (123-i) - injektionsvæske
sodium iodide (131 i) diagn. capsules ge healthcar kapsler, hårde
ge healthcare buchler gmbh . & co kg - natriumiodid (131-i) - kapsler, hårde
sodium iodide (131 i) injection ge healthcare limi injektionsv?ske
ge healthcare buchler gmbh . & co kg - natriumiodid (131-i) - injektionsvæske
sodium iodide (i123) injection injektionsvæske, opløsning
curium netherlands b.v. - natriumiodid (123-i) - injektionsvæske, opløsning
sodium iodide (i131) capsules t kapsler, hårde
curium netherlands b.v. - natriumiodid (131-i) - kapsler, hårde
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.